Cited by 734Telomeres, Telomerase, and SenescenceImmunotherapy and Immune ResponsesVirus-based gene therapy research

The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.

Telomerase and cancer therapeutics

Harley, Calvin B.·2008·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Telomerase is an attractive cancer target as it appears to be required in essentially all tumours for immortalization of a subset of cells, including cancer stem cells. Moreover, differences in telomerase expression, telomere length and cell kinetics between normal and tumour tissues suggest that targeting telomerase would be relatively safe. Clinical trials are ongoing with a potent and specific telomerase inhibitor, GRN163L, and with several versions of telomerase therapeutic vaccines. The prospect of adding telomerase-based therapies to the growing list of new anticancer products is promising, but what are the advantages and limitations of different approaches, and which patients are the most likely to respond?

Integrity signals

Registry

Crossref · 10.1038/nrc2275

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama, M., Hideshima, T., Shammas, M. A., Hayashi, T., Hamasaki, M., Tai, Y., Richardson, P. G. G., Gryaznov, S. M., Munshi, N. C., & Anderson, K. C. (2003) · PubMed · Cited by 84
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citation
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citation
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280

Flagged first, then by citations

Show all 147 references

Research works printed but not linked: 1

Dikmen, Z. et al. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 7866–7873 (2005). · DOI · Paper page

Sorted by citations

Items 201–300 of 734

Environmental pollutants exposure: A potential contributor for aging and age-related diseases
Liu, Y., Wang, J., Huang, Z., Liang, J., Xia, Q., Xia, Q., & Liu, X. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103575 · Cited by 46
BRD4 inhibitors block telomere elongation
Wang, S., Pike, A. M., Lee, S. S., Strong, M. A., Connelly, C. J., & Greider, C. W. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx561 · Cited by 45
Changes of telomere status with aging: An update
Ishikawa, N., Nakamura, K., Izumiyama‐Shimomura, N., Aida, J., Matsuda, Y., Arai, T., & Takubo, K. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12772 · Cited by 45
Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells
El-Badawy, A., Ghoneim, N. I., Nasr, M. A., Elkhenany, H. A., Ahmed, T. A., Ahmed, S. M., & El‐Badri, N. (2018) · Biology Open · doi:10.1242/bio.034181 · Cited by 44
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach
Platella, C., Raucci, U., Rega, N., D’Atri, S., Levati, L., Roviello, G. N., Fuggetta, M. P., Musumeci, D., & Montesarchio, D. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.160 · Cited by 44
The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells
Rossi, A., Russo, G. M., Puca, A., Montagna, R. L., Caputo, M., Mattioli, E., Lopez, M., Giordano, A., & Pentimalli, F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24331 · Cited by 43
Tpz1 controls a telomerase-nonextendible telomeric state and coordinates switching to an extendible state via Ccq1Preprint
Jun, H.-I., Liu, J., Jeong, H., Kim, J., & Qiao, F. (2013) · Genes & Development · doi:10.1101/gad.219485.113 · Cited by 47
Integrated regulation of PIKK-mediated stress responses by AAA+ proteins RUVBL1 and RUVBL2
Izumi, N., Yamashita, A., & Ohno, S. (2012) · Nucleus · doi:10.4161/nucl.18926 · Cited by 48
G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors
Shalaby, T., Fiaschetti, G., Nagasawa, K., Shin‐ya, K., Baumgartner, M., & Grotzer, M. A. (2013) · Molecules · doi:10.3390/molecules181012500 · Cited by 46
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas
Wesbuer, S., Lanvers‐Kaminsky, C., Duran-Seuberth, I., Bölling, T., Schäfer, K.-L., Braun, Y., Willich, N. A., & Greve, B. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-66 · Cited by 43
Multivalent Self-Assembled DNA Polymer for Tumor-Targeted Delivery and Live Cell Imaging of Telomerase Activity
Zhu, X., Ye, H., Liu, J., Yu, R., & Jiang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04631 · Cited by 43
HnRNP F/H associate with hTERC and telomerase holoenzyme to modulate telomerase function and promote cell proliferation
Xu, C., Xie, N., Su, Y., Sun, Z., Liang, Y., Zhang, N., Liu, D., Jia, S., Xing, X., Han, L., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0483-6 · Cited by 46
Targeted Therapy of TERT -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Chen, J., Nelson, C. B., Wong, M., Tee, A. E., Liu, P. Y., La, T., Fletcher, J. I., Kamili, A., Mayoh, C., Bartenhagen, C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3044 · Cited by 42
New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small Cell Lung Cancer
Tawfik, H. O., El-Hamaky, A. A., El-Bastawissy, E. A., Shcherbakov, K. A., Veselovsky, A. V., Gladilina, Y. A., Zhdanov, D. D., & El‐Hamamsy, M. H. (2022) · Pharmaceuticals · doi:10.3390/ph15040481 · Cited by 43
Telomerase: A prominent oncological target for development of chemotherapeutic agents
Vishwakarma, K., Dey, R., & Bhatt, H. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115121 · Cited by 44
HPV16 E7 Protein and hTERT Proteins Defective for Telomere Maintenance Cooperate to Immortalize Human Keratinocytes
Miller, J., Dakic, A., Chen, R., Palechor-Ceron, N., Dai, Y., Kallakury, B., Schlegel, R., & Liu, X. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003284 · Cited by 42
Targeting the telosome: Therapeutic implications
Folini, M., Gandellini, P., & Zaffaroni, N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.014 · Cited by 44
Hippocampal TERT Regulates Spatial Memory Formation through Modulation of Neural Development
Zhou, Q.-G., Liu, M., Lee, H., Ishikawa, F., Devkota, S., Shen, X.-R., Jin, X., Wu, H.-Y., Liu, Z., Liu, X., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.014 · Cited by 43
Editorial: Our Top 10 Developments in Stem Cell Biology over the Last 30 Years
Armstrong, L., Lako, M., Buckley, N. J., Lappin, T. R. J., Murphy, M. J., Nolta, J. A., Pittenger, M. F., & Stojković, M. (2011) · Stem Cells · doi:10.1002/stem.1007 · Cited by 43
Pancreatic cancer stem cells – insights and perspectives
Hermann, P. C., Mueller, M.-T., & Heeschen, C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903246362 · Cited by 41
Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis
Rocchi, L., Barbosa, A. J. M., Onofrillo, C., Río, A. D., & Montanaro, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101971 · Cited by 41
Prostate tumor-initiating cells: A new target for telomerase inhibition therapy?
Marian, C. O., & Shay, J. W. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.012 · Cited by 41
A cascade amplification approach for visualization of telomerase activity in living cells
Yan, L., Hui, J., Liu, Y., Guo, Y., Liu, L., Ding, L., & Ju, H. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.07.102 · Cited by 41
Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells
Ahmed, M., Chaudhari, K., Babaei‐Jadidi, R., Dekker, L. V., & Nateri, A. S. (2017) · Stem Cells · doi:10.1002/stem.2579 · Cited by 42
New Approaches to Myelodysplastic Syndrome Treatment
Bazinet, A., & Bravo, G. M. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00965-1 · Cited by 40
Natural products targeting telomere maintenance
Chen, J. L.-Y., Sperry, J., Ip, N. Y., & Brimble, M. A. (2011) · MedChemComm · doi:10.1039/c0md00241k · Cited by 41
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
Shaw, V. E., Naisbitt, D. J., Costello, E., Greenhalf, W., Park, B., Neoptolemos, J. P., & Middleton, G. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.92 · Cited by 40
A “Signal On” Photoelectrochemical Biosensor Based on Bismuth@N,O‐Codoped‐Carbon Core‐Shell Nanohybrids for Ultrasensitive Detection of Telomerase in HeLa Cells
Liu, S., Zhao, S., Tu, W., Wang, X., Wang, X., Bao, J., Wang, Y., Han, M., & Dai, Z. H. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201704251 · Cited by 40
Recent developments in novel blue/green/red/NIR small fluorescent probes for in cellulo tracking of RNA/DNA G-quadruplexes
Pandith, A., Kumara, G. S. R., & Seo, Y. J. (2019) · Journal of Photochemistry and Photobiology C Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2019.08.001 · Cited by 40
Direct Short-Term Cytotoxic Effects of BIBR 1532 on Acute Promyelocytic Leukemia Cells Through Induction of p21 Coupled with Downregulation of c-Myc and hTERT Transcription
Bashash, D., Ghaffari, S. H., Zaker, F., Hezave, K., Pasikhani, M. K., Ghavamzadeh, A., Alimoghaddam, K., Mossavi, S. A., Gharehbaghian, A., & Vossough, P. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.629378 · Cited by 40
Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo
Shi, Y., Zhao, Q., Zhang, L., Du, W., Wang, X., He, X., Wu, S., & Li, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2493 · Cited by 40
Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo
Adotévi, O., Mollier, K., Neuveut, C., Dosset, M., Ravel, P., Fridman, W. H., Tartour, É., Charneau, P., Wain–Hobson, S., & Langlade‐Demoyen, P. (2010) · Blood · doi:10.1182/blood-2009-11-253641 · Cited by 40
Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC
Gourronc, F. A., Robertson, M. M., Herrig, A. K., Lansdorp, P. M., Goldman, F. D., & Klingelhutz, A. J. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00916.x · Cited by 39
Ginger Extract Inhibits Human Telomerase Reverse Transcriptase and c-Myc Expression in A549 Lung Cancer Cells
Tuntiwechapikul, W., Taka, T., Songsomboon, C., Kaewtunjai, N., Imsumran, A., Makonkawkeyoon, L., Pompimon, W., & Lee, T. R. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.1191 · Cited by 40
Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation
Huang, H., Chiang, Y., Cheng, W., Chen, C., Lin, M.-C., & Kuo, K. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.93 · Cited by 38
Histone Deacetylase Inhibition Attenuates Cell Growth with Associated Telomerase Inhibition in High-Grade Childhood Brain Tumor Cells
Rahman, R., Osteso-Ibáñez, T., Hirst, R. A., Levesley, J., Kilday, J., Quinn, S., Peet, A. C., O’Callaghan, C., Coyle, B., & Grundy, R. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0272 · Cited by 40
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy
Keller, G., Brassat, U., Braig, M., Heim, D., Wege, H., & Brümmendorf, T. H. (2009) · Hematological Oncology · doi:10.1002/hon.901 · Cited by 40
Development of anticancer drugs based on the hallmarks of tumor cells
Bailón-Moscoso, N., Romero-Benavides, J. C., & Ostrosky‐Wegman, P. (2014) · Tumor Biology · doi:10.1007/s13277-014-1649-y · Cited by 44
The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression
Zhang, X., Li, B., de Jonge, N., Björkholm, M., & Xu, D. (2015) · Oncotarget · doi:10.18632/oncotarget.2917 · Cited by 38
Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
Mimeault, M., & Batra, S. K. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00885.x · Cited by 38
Senescence; an endogenous anticancer mechanism
Vargas, J. E. (2012) · Frontiers in bioscience · doi:10.2741/4074 · Cited by 38
PML-IV functions as a negative regulator of telomerase by interacting with TERT
Oh, W., Ghim, J., Lee, E., Yang, M.-R., Kim, E. T., Ahn, J.-H., & Song, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.048066 · Cited by 39
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response
Thalmensi, J., Pliquet, É., Liard, C., Escande, M. C., Bestetti, T., Julithe, M., Kostrzak, A., Jimenez, A., Bourges, E., Loustau, M., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1083670 · Cited by 42
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
Liu, W., Yin, Y., Wang, J., Shi, B., Zhang, L., Qian, D., Li, C., Zhang, H., Wang, S., Zhu, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10162 · Cited by 40
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
Tagliamonte, M., Petrizzo, A., Napolitano, M., Luciano, A., Arra, C., Maiolino, P., Izzo, F., Tornesello, M. L., Aurisicchio, L., Ciliberto, G., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1698-0 · Cited by 38
Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2′-O-methyl-RNA
Dong, M., Philippi, C., Loretz, B., Nafee, N. A., Schaefer, U. F., Friedel, G., Ammon-Treiber, S., Griese, E., Lehr, C., Klotz, U. E., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.009 · Cited by 36
Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells
Bashash, D., Ghaffari, S. H., Khalilabadi, R. M., Alimoghaddam, K., & Ghavamzadeh, A. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.704034 · Cited by 37
Structures of telomerase subunits provide functional insights
Sekaran, V. G., Soares, J., & Jarstfer, M. B. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.019 · Cited by 36
TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer
Wang, K., Liu, T., Liu, C., Meng, Y., Yuan, X., Liu, L., Ge, N., Liu, J., Wang, C., Ren, H., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0391 · Cited by 36
Pyrazinoporphyrazines with Externally Appended Pyridine Rings. 13. Structure, UV–Visible Spectral Features, and Noncovalent Interaction with DNA of a Positively Charged Binuclear (ZnII/PtII) Macrocycle with Multimodal Anticancer Potentialities
Manet, I. G. J., Manoli, F., Donzello, M. P., Viola, E., Masi, A., Andreano, G., Ricciardi, G., Rosa, A., Cellai, L., Ercolani, C., et al. (2012) · Inorganic Chemistry · doi:10.1021/ic3020755 · Cited by 36
Human telomerase reverse transcriptase positively regulates mitophagy by inhibiting the processing and cytoplasmic release of mitochondrial PINK1
Shin, W. H., & Chung, K. C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2641-7 · Cited by 37
Copper( ii ) l / d -valine-(1,10-phen) complexes target human telomeric G-quadruplex motifs and promote site-specific DNA cleavage and cellular cytotoxicity
Arjmand, F., Sharma, S., Parveen, S., TOUPET, L. J., Yu, Z., & Cowan, J. A. (2020) · Dalton Transactions · doi:10.1039/d0dt01527j · Cited by 37
New Trends in Molecular Biomarker Discovery for Breast Cancer
Radpour, R., Barekati, Z., Kohler, C., Holzgreve, W., & Zhong, X. Y. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2009.0060 · Cited by 36
Association between the Telomerase Reverse Transcriptase (TERT) rs2736098 Polymorphism and Cancer Risk: Evidence from a Case-Control Study of Non-Small-Cell Lung Cancer and a Meta-Analysis
Wu, H., Qiao, N., Wang, Y., Jiang, M., Wang, S., Wang, C., & Hu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076372 · Cited by 36
Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways
Bernhart, E. M., Damm, S., Heffeter, P., Wintersperger, A., Asslaber, M., Frank, S., Hammer, A., Strohmaier, H. M., DeVaney, T. T. J., Mrfka, M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not303 · Cited by 33
Enhanced anticancer potency by combination chemotherapy of HT-29 cells with biodegradable, pH-sensitive nanoparticles for co-delivery of hydroxytyrosol and doxorubicin
Ahmadi, E., Zarghami, N., Jafarabadi, M. A., Alizadeh, L., Khojastehfard, M., Yamchi, M. R., & Salehi, R. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.003 · Cited by 36
Non-invasive diagnosis of bladder cancer by detecting telomerase activity in human urine using hybridization chain reaction and dynamic light scattering
Li, T., Zou, L., Zhang, J., Li, G., & Ling, L. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.03.039 · Cited by 34
Telomere elongation-based DNA-Catalytic amplification strategy for sensitive SERS detection of telomerase activity
Li, Y., Han, H., Wu, Y., Yu, C., Ren, C., & Zhang, X. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111543 · Cited by 35
Potential roles of telomeres and telomerase in neurodegenerative diseases
Wang, J., Liu, Y., Xia, Q., Xia, Q., Wang, B., Yang, C., Liang, J., & Liu, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.046 · Cited by 37
RHPS4 G-Quadruplex Ligand Induces Anti-Proliferative Effects in Brain Tumor Cells
Lagah, S., Tan, I., Radhakrishnan, P., Hirst, R. A., Ward, J. H., O’Callaghan, C., Smith, S. J., Stevens, M. F. G., Grundy, R. G., & Rahman, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086187 · Cited by 35
Pancreatic cancer stem cells: new insights and perspectives
Dorado, J., Lonardo, E., Miranda‐Lorenzo, I., & Heeschen, C. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0422-x · Cited by 35
Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex
Belgiovine, C., Chiodi, I., & Mondello, C. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167811 · Cited by 34
Comparison of Genomics and Functional Imaging from Canine Sarcomas Treated with Thermoradiotherapy Predicts Therapeutic Response and Identifies Combination Therapeutics
Chi, J., Thrall, D. Ε., Chen, J., Snyder, S. A., Fels, D. R., Landon, C. D., McCall, L. M., Lan, L., Hauck, M., MacFall, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2583 · Cited by 35
The Biology of Aging and Lymphoma: a Complex Interplay
Sarkozy, C., Salles, G. A., & Falandry, C. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0457-x · Cited by 36
A novel hTERT promoter–driven E1A therapeutic for ovarian cancer
Xie, X., Hsu, J. L., Choi, M. G., Xia, W., Yamaguchi, H., Chen, C., Trinh, B. Q., Lü, Z., Ueno, N. T., Wolf, J. K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0056 · Cited by 34
KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth
Hu, W., Jia, Y., Xiao, X., Lv, K., Chen, Y., Wang, L., Luo, X., Liu, T., Li, W., Li, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9141 · Cited by 33
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis
Ayiomamitis, G. D., Notas, G., Vasilakaki, T., Tsavari, A., Vederaki, S., Theodosopoulos, T., Kouroumalis, E., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101536 · Cited by 34
DNA-Based nanostructures for tumor microenvironment-responsive drug delivery
Li, S., Xu, M., Yao, C., & Yang, D. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115610 · Cited by 34
Telomere/telomerase interplay in virus‐driven and virus‐independent lymphomagenesis: pathogenic and clinical implications
Dolcetti, R., & Rossi, A. D. (2010) · Medicinal Research Reviews · doi:10.1002/med.20211 · Cited by 34
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes
Ugel, S., Scarselli, E., Iezzi, M., Mennuni, C., Pannellini, T., Calvaruso, F., Cipriani, B., Palma, R. D., Ricci‐Vitiani, L., Peranzoni, E., et al. (2009) · Blood · doi:10.1182/blood-2009-07-233270 · Cited by 33
Interactions of a Platinum-Modified Perylene Derivative with the Human Telomeric G-Quadruplex
Rao, L., Dworkin, J. D., Nell, W. E., & Bierbach, U. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp207265s · Cited by 33
Single-molecule fluorescence resonance energy transfer and its biomedical applications
Li, C.-C., Li, Y., Zhang, Y., & Zhang, C. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115753 · Cited by 33
A Cajal body-independent pathway for telomerase trafficking in mice
Tomlinson, R. L., Li, J., Culp, B. R., Terns, R. M., & Terns, M. P. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.07.001 · Cited by 34
Telomerase inhibition improves tumor response to radiotherapy in a murine orthotopic model of human glioblastoma
Ferrandon, S., Malleval, C., Hamdani, B. E., Battiston-Montagne, P., Bolbos, R. I., Langlois, J., Manas, P., Gryaznov, S. M., Alphonse, G., Honnorat, J., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0376-3 · Cited by 33
Effects of Mitochondrial Translocation of Telomerase on Drug Resistance in Hepatocellular Carcinoma Cells
Yan, J., Zhou, Y., Chen, D., Li, L., Yang, X. X., You, Y., & Ling, X. (2015) · Journal of Cancer · doi:10.7150/jca.10419 · Cited by 33
Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis
Bateman, G., Guo-Parke, H., Rodgers, A. M., Linden, D. A., Bailey, M., Weldon, S., Kidney, J. C., & Taggart, C. C. (2023) · Biomedicines · doi:10.3390/biomedicines11072072 · Cited by 39
Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks
Wu, X., Smavadati, S., Nordfjäll, K., Karlsson, K., Qvarnström, F., Simonsson, M., Bergqvist, M., Gryaznov, S. M., Ekman, S., & Paulsson-Karlsson, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.003 · Cited by 33
Hdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERT
Oh, W., Lee, E.-W., Lee, D., Yang, M.-R., Ko, A., Yoon, C.-H., Lee, H. W., Bae, Y.-S., Choi, C. Y., & Song, J. (2010) · Oncogene · doi:10.1038/onc.2010.160 · Cited by 32
Telomere Targeting Chimera Enables Targeted Destruction of Telomeric Repeat-Binding Factor Proteins
Wang, Z., Liu, J., Chen, H., Qiu, X., Xie, L., Kanıskan, H. Ü., Chen, X., Jin, J. J., & Wei, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02783 · Cited by 32
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA)
Ali, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 36
Formation and stabilization of the telomeric antiparallel G-quadruplex and inhibition of telomerase by novel benzothioxanthene derivatives with anti-tumor activity
Zhang, W., Chen, M., Wu, Y. L., Tanaka, Y., Ji, Y. J., Zhang, S. L., Wei, C. H., & Xu, Y. (2015) · Scientific Reports · doi:10.1038/srep13693 · Cited by 37
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas
Chen, W., Qin, L., Wang, S., Li, M., Shi, D., Tian, Y., Wang, J., Fu, L., Li, Z., Guo, W., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.001 · Cited by 32
Changed Genome Heterochromatinization Upon Prolonged Activation of the Raf/ERK Signaling Pathway
Martin, C., Chen, S., Heilos, D., Sauer, G., Hunt, J. R., Shaw, A., Sims, P. F. G., Jackson, D. A., & Lovrić, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013322 · Cited by 31
Structural Basis for Shelterin Bridge Assembly
Kim, J., Liu, J., Hu, X., Yu, C., Roskamp, K. W., Sankaran, B., Huang, L., Komives, E. A., & Qiao, F. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.10.032 · Cited by 31
Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes
Ameri, Z., Ghiasi, S., Farsinejad, A., Hassanshahi, G., Ehsan, M., & Fatemi, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.060 · Cited by 32
MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway
Fatemi, A., Safa, M., & Kazemi, A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3575-z · Cited by 32
Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design
Mascarenhas, J. O., Harrison, C. N., Kiladjian, J., Komrokji, R. S., Koschmieder, S., Vannucchi, A. M., Berry, T., Redding, D., Sherman, L. J., Dougherty, S., et al. (2022) · Future Oncology · doi:10.2217/fon-2022-0235 · Cited by 33
Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations
Noureini, S. K., & Tanavar, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.02.020 · Cited by 31
Study on the electrocatalytic activity of human telomere G-quadruplex–hemin complex and its interaction with small molecular ligands
Yang, Q., Nie, Y., Zhu, X., Liu, X., & Li, G. (2009) · Electrochimica Acta · doi:10.1016/j.electacta.2009.08.050 · Cited by 30
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives
Bilsland, A. E., Cairney, C. J., & Keith, W. N. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01253.x · Cited by 31
Fluorescence detection of telomerase activity in cancer cell extracts based on autonomous exonuclease III-assisted isothermal cycling signal amplification
Ding, C., Li, X., Wang, W., & Chen, Y. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.04.012 · Cited by 30
Rational Design of Framework Nucleic Acids for Bioanalytical Applications
Su, Y., Li, D., Liu, B., Xiao, M., Wang, F., Li, L., Zhang, X., & Pei, H. (2019) · ChemPlusChem · doi:10.1002/cplu.201900118 · Cited by 30
Telomeres and disease: Enter TERRA
Maicher, A., Kastner, L., & Luke, B. (2012) · RNA Biology · doi:10.4161/rna.20330 · Cited by 30
Telomere Dysfunction and DNA Damage Checkpoints in Diseases and Cancer of the Gastrointestinal Tract
Rudolph, K. L., Hartmann, D., & Opitz, O. G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.037 · Cited by 32
hTERT Inhibition Triggers Epstein–Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies
Giunco, S., Dolcetti, R., Keppel, S., Celeghin, A., Indraccolo, S., Col, J. D., Mastorci, K., & Rossi, A. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2537 · Cited by 30
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas
Lin, P., Lin, S., Chen, Y.-L., Chang, J., Ho, L.-I., Liu, P.-Y., Chang, L.-F., Harn, Y., Chen, S., Sun, L., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1644-0 · Cited by 30
A cationic Zn II porphyrazine induces a stable parallel G-quadruplex conformation in human telomeric DNA
Manet, I. G. J., Manoli, F., Donzello, M. P., Viola, E., Andreano, G., Masi, A., Cellai, L., & Monti, S. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00598c · Cited by 29
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy
Eckburg, A., Dein, J., Berei, J., Schrank, Z., & Puri, N. (2020) · Cancers · doi:10.3390/cancers12092337 · Cited by 29
The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma
Hu, Y., Bobb, D., He, J., Hill, D. A., & Dome, J. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1040964 · Cited by 30
Tetra-2,3-pyrazinoporphyrazines with Externally Appended Pyridine Rings. 10. A Water-Soluble Bimetallic (ZnII/PtII) Porphyrazine Hexacation as Potential Plurimodal Agent for Cancer Therapy: Exploring the Behavior as Ligand of Telomeric DNA G-Quadruplex Structures
Manet, I. G. J., Manoli, F., Donzello, M. P., Ercolani, C., Vittori, D., Cellai, L., Masi, A., & Monti, S. (2011) · Inorganic Chemistry · doi:10.1021/ic200514z · Cited by 28

Authors: Harley, C. B.
Affiliations: Geron (United States) (US)
Corresponding author: Harley, Calvin B.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2008-03
Volume: 8
Issue: 3
Pages: 167-179
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2275
OpenAlex: W2078805336
Cited by: 728
References: 147
Citations by year: 2026: 11 · 2025: 22 · 2024: 26 · 2023: 39 · 2022: 20 · 2021: 29 · 2020: 38 · 2019: 39 · 2018: 27 · 2017: 38 · 2016: 48 · 2015: 58 · 2014: 48 · 2013: 51 · 2012: 53
FWCI: 6.57
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords: telomerase, telomerase inhibitors, GRN163L, cancer therapeutics, cancer stem cells, telomere length, cell kinetics, anticancer drug development
MeSH terms: Antineoplastic Agents, Clinical Trials as Topic, Enzyme Inhibitors, Humans, Immunotherapy, Kinetics, Medical Oncology, Models, Biological, Neoplasms, Oligonucleotides, Oligopeptides, Gene Expression Regulation, Neoplastic, Telomerase, Cancer Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Telomerase and cancer therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks